Nivolumab Extends Survival in Advanced Renal Cell Carcinoma
September 25, 2015Jason M. BroderickNivolumab reduced the risk of death by 27% versus everolimus in patients with advanced renal cell carcinoma, improving overall survival by 5.4 months.Padmanee Sharm
Updated on: October 24,2023
4
Nivolumab Extends Survival in Advanced Renal Cell Carcinoma
September 25, 2015Jason M. BroderickNivolumab reduced the risk of death by 27% versus everolimus in patients with advanced renal cell carcinoma, improving overall survival by 5.4 months.Padmanee Sharm
Updated on:October 24,2023
4